Latest California Healthline Stories
Are You And Your Primary Care Doc Ready To Talk About Your DNA?
The Pennsylvania-based health chain Geisinger plans to offer DNA sequencing as part of regular patient care.
Indocumentada y con cáncer: entre la muerte y la deportación
¿Qué sucede cuando un inmigrante indocumentado tiene un diagnóstico potencialmente mortal? Depende mucho de en dónde viva.
Choosing Between Death And Deportation
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
‘Rapid Autopsy’ Programs Seek Clues To Cancer Within Hours Of Death
More than a dozen centers nationwide now ask terminal patients to allow speedy study of the diseases that kill them.
When You Need A Breast Screening, Should You Get A 3-D Mammogram?
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
¿Son necesarias las mamografías en tres dimensiones?
Cada vez más centros de imágenes ofrecen esta alternativa, en vez de la mamografía tradicional. Sin embargo, expertos sugieren no recomendarlas ampliamente todavía.
Inside The Global Race To Deliver A Vital Radioactive Isotope Used To Detect Cancer
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Study Gives Mixed Reviews To Laws To Equalize Cancer Patients’ Out-Of-Pocket Costs
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
California Cracks Down On Weed Killer As Lawsuits Abound
California has listed the active ingredient in Monsanto’s Roundup as a cancer-causing agent and will require warning labels on it starting next year. The company says the listing is unjustified and science is on its side.